CUV clinuvel pharmaceuticals limited

Ann: Preliminary results from SCENESSE adolescent EPP study, page-4

  1. 905 Posts.
    lightbulb Created with Sketch. 373
    the market loves it. Preliminary “data” from 14 patients for a trial that was committed to in 2014. Should expand market size by 30 -40 patients. Trial performed after ema rejection. Love this company.https://hotcopper.com.au/data/attachments/6797/6797984-cc31ffd6c62890679f07007b77b57bbf.jpg

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.56
Change
0.450(3.72%)
Mkt cap ! $628.5M
Open High Low Value Volume
$12.05 $12.59 $12.00 $1.100M 89.13K

Buyers (Bids)

No. Vol. Price($)
4 55 $12.55
 

Sellers (Offers)

Price($) Vol. No.
$12.56 186 3
View Market Depth
Last trade - 14.01pm 29/07/2025 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.